Literature DB >> 30649581

[Organ preservation in cancer of the upper urinary tract].

F Vom Dorp1.   

Abstract

Urothelial carcinoma of the upper urinary tract is a rare disease. Tumor biology is comparable to transitional cell carcinomas of the bladder. Local tumor control is much more difficult to achieve in the upper urinary tract than in the bladder. Radical nephroureterectomy is often performed due to carcinomas with low grade histology. Progression rates in these cases are rare; overtreatment has to be discussed. The current article uses the available published data to discuss whether local treatment is an option for tumors of the upper urinary tract. Summarizing the available data, it is indicated that if complete resectability is possible organ preservation is equivalent to radical nephroureterectomy independent of the T‑ and G‑category of the tumor.

Entities:  

Keywords:  Carcinoma in situ; Lynch syndrome; Nephroureterectomy; Overtreatment; Urothelial carcinoma

Mesh:

Year:  2019        PMID: 30649581     DOI: 10.1007/s00120-018-0831-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  17 in total

Review 1.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

Authors:  Giovanni Lughezzani; Maximilian Burger; Vitaly Margulis; Surena F Matin; Giacomo Novara; Morgan Roupret; Shahrokh F Shariat; Christopher G Wood; Richard Zigeuner
Journal:  Eur Urol       Date:  2012-02-23       Impact factor: 20.096

2.  A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.

Authors:  Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-12-06       Impact factor: 2.649

3.  Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.

Authors:  Mark L Cutress; Grant D Stewart; Edward C G Tudor; Eric A Egong; Simon Wells-Cole; Simon Phipps; Ben G Thomas; Antony C P Riddick; S Alan McNeill; David A Tolley
Journal:  J Urol       Date:  2012-12-07       Impact factor: 7.450

4.  Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

Authors:  Adil Ouzzane; Pierre Colin; Evanguelos Xylinas; Geraldine Pignot; Mehdi Mokhtar Ariane; Fabien Saint; Nicolas Hoarau; Emilie Adam; Marie Dominique Azemar; Henri Bensadoun; Luc Cormier; Olivier Cussenot; Alain Houlgatte; Gilles Karsenty; Franck Bruyère; Charlotte Maurin; François Xavier Nouhaud; Véronique Phe; Thomas Polguer; Mathieu Roumiguié; Alain Ruffion; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-06-07       Impact factor: 20.096

5.  Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.

Authors:  Akihiro Ito; Ichiro Shintaku; Makoto Satoh; Naomasa Ioritani; Tatsuo Tochigi; Isao Numata; Takashige Namima; Koichi Kambe; Atsushi Kyan; Seiji Ueno; Shinnosuke Katoh; Hisanobu Adachi; Shinichi Yamashita; Takuhiro Yamaguchi; Yoichi Arai
Journal:  Jpn J Clin Oncol       Date:  2013-09-04       Impact factor: 3.019

6.  Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.

Authors:  Michael Grasso; Andrew I Fishman; Jacob Cohen; Bobby Alexander
Journal:  BJU Int       Date:  2012-03-28       Impact factor: 5.588

7.  Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.

Authors:  Amy E Krambeck; R Houston Thompson; Christine M Lohse; David E Patterson; Joseph W Segura; Horst Zincke; Daniel S Elliott; Michael L Blute
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

8.  The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.

Authors:  Thomas F Chromecki; Eugene K Cha; Harun Fajkovic; Vitaly Margulis; Giacomo Novara; Douglas S Scherr; Yair Lotan; Jay D Raman; Wassim Kassouf; Karim Bensalah; Alon Weizer; Eiji Kikuchi; Marco Roscigno; Mesut Remzi; Kazumasa Matsumoto; Thomas J Walton; Armin Pycha; Vincenzo Ficarra; Pierre I Karakiewicz; Richard Zigeuner; Karl Pummer; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2011-09-28       Impact factor: 20.096

9.  Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Authors:  Faysal A Yafi; Giacomo Novara; Shahrokh F Shariat; Amit Gupta; Kazumasa Matsumoto; Thomas J Walton; Hans-Martin Fritsche; Assaad El-Hakim; Stefan Trischler; Juan I Martínez-Salamanca; Christian Seitz; Vincenzo Ficarra; Filiberto Zattoni; Pierre I Karakiewicz; Wassim Kassouf
Journal:  BJU Int       Date:  2011-12-16       Impact factor: 5.588

Review 10.  Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance.

Authors:  Marie-Dominique Azémar; Eva Comperat; François Richard; Olivier Cussenot; Morgan Rouprêt
Journal:  Urol Oncol       Date:  2009-09-17       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.